Bayforest Capital’s Halozyme HALO Stock Holding History

Bayforest Capital’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62	Closed	-$3.23K	–	815
2025 Q2	$3.23K	Buy	62 +16	+35%	+$910	﹤0.01%	683
2025 Q1	$2.94K	Buy	+46	New	+$2.67K	﹤0.01%	699

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bayforest Capital's HALO Position: Q3 2025 in Review

Bayforest Capital sold out of Halozyme (HALO) in Q3 2025, closing a stake of 62 shares — an estimated $3.23K sold.

Bayforest Capital first reported a position in HALO in Q1 2025 and held it in 2 quarters. The position peaked at $3.23K in Q2 2025. 602 funds tracked by Wall St. Rank hold HALO as of Q3 2025.

Bayforest Capital reported no remaining Halozyme position as of Q3 2025 after selling out during the quarter.
Bayforest Capital sold 62 Halozyme shares in Q3 2025, an estimated $3.23K.
Bayforest Capital first reported a position in Halozyme in Q1 2025 and held it in 2 quarters.
Bayforest Capital's Halozyme position peaked at $3.23K in Q2 2025.
602 funds tracked by Wall St. Rank held Halozyme as of Q3 2025.

Based on Bayforest Capital's 13F filing for Q3 2025, filed 24 Oct 2025.